Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Crisaborole

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 5,713Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Padagis Starts Life Post-Perrigo With Eucrisa Challenge
    Padagis Starts Life Post-Perrigo With Eucrisa Challenge

    12 Oct 2021

    // David Wallace PHARMAINTELLIGENCE

    https://generics.pharmaintelligence.informa.com/GB151320/Padagis-Starts-Life-Post-Perrigo-With-Eucrisa-Challenge

    David Wallace PHARMAINTELLIGENCE
    12 Oct 2021
    Share Share
    Padagis Confirms First-to-File Patent Challenge For Generic Version Of Eucrisa®
    Padagis Confirms First-to-File Patent Challenge For Generic Version Of Eucrisa®

    28 Sep 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/padagis-confirms-first-to-file-patent-challenge-for-generic-version-of-eucrisa-301387193.html

    PRNEWSWIRE
    28 Sep 2021
    Share Share
    Pfizer Europe Generic Staquis(Crisaborole) Receives Approval In Europe
    Pfizer Europe Generic Staquis(Crisaborole) Receives Approval In Europe

    22 Apr 2020

    // EMA

    https://www.ema.europa.eu/en/documents/overview/staquis-epar-medicine-overview_en.pdf

    EMA
    22 Apr 2020
    Share Share
    U.S. FDA Approves Supplemental sNDA for Expanded Indication of EUCRISA®
    U.S. FDA Approves Supplemental sNDA for Expanded Indication of EUCRISA®

    24 Mar 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200324005177/en/U.S.-FDA-Approves-Supplemental-New-Drug-Application/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==

    BUSINESSWIRE
    24 Mar 2020
    Share Share
    Givlaari, Nubeqa among Jan CHMP decisions
    Givlaari, Nubeqa among Jan CHMP decisions

    03 Feb 2020

    // Anna Smith PHARMATIMES

    http://www.pharmatimes.com/news/givlaari,_nubeqa_among_jan_chmp_decisions_1323999

    Anna Smith PHARMATIMES
    03 Feb 2020
    Share Share
    Hey, big spender: Pharma's $6.6B TV ad outlay outranks most other industries
    Hey, big spender: Pharma's $6.6B TV ad outlay outranks most other industries

    16 May 2019

    // Beth Snyder Bulik FIERCE PHARMA

    https://www.fiercepharma.com/marketing/hey-big-spenders-pharma-ranks-top-five-industries-for-tv-media-spending-says-report

    Beth Snyder Bulik FIERCE PHARMA
    16 May 2019
    Share Share